ConductScience.org, home

Paper · 95015

Monoclonal antibodies for analysis of the HLA system.

Brodsky FM and 4 others. Immunol Rev, 1979. Cited by 799 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Monoclonal antibodies for analysis of the HLA system. Papers, record 95015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/95015

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Monoclonal antibodies for analysis of the HLA system.
PubMed
Journal
Immunol Rev
PubMed
Year
1979
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
799
iCite
Relative citation ratio, by iCite
18.9
iCite
Revised in PubMed
2019-09-11
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brodsky FMF M
2Parham PP
3Barnstable CJC J
4Crumpton MJM J
5Bodmer WFW F

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntibodiesMajor topic
HLA AntigensMajor topic
Major Histocompatibility ComplexMajor topic
Animals
Antibody Specificity
Cell Fusion
Clone Cells
Complement C2
Complement C4
Cytotoxicity, Immunologic
Epitopes
Haplorhini
Humans
Hybrid Cells
Immunization
Immunochemistry
Mice
Species Specificity

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by221

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 799 citations.

PMIDTitleJournalYearIn PapersSource
41,002,377Novel BCR-Targeting Fusion Proteins for Antigen-Specific Depletion of Alloreactive B Cells in Antibody-Mediated Rejection.Cells2025https://conductscience.org/library/papers/41002377PubMed
40,426,019Increasing the odds: antibody-mediated delivery of two distinct immunogenic T-cell epitopes with one antibody.Oncoimmunology2025https://conductscience.org/library/papers/40426019PubMed
38,900,146Multimodal HLA-I genotype regulation by human cytomegalovirus US10 and resulting surface patterning.Elife2024https://conductscience.org/library/papers/38900146PubMed
38,456,672Experimental Structures of Antibody/MHC-I Complexes Reveal Details of Epitopes Overlooked by Computational Prediction.J Immunol2024https://conductscience.org/library/papers/38456672PubMed
38,106,040Experimental structures of antibody/MHC-I complexes reveal details of epitopes overlooked by computational prediction.bioRxiv2023https://conductscience.org/library/papers/38106040PubMed
37,945,970Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8+ T-cell immunity towards cancer cells.Cancer Gene Ther2024https://conductscience.org/library/papers/37945970PubMed
37,636,243A historical perspective on HLA.Immunother Adv2023https://conductscience.org/library/papers/37636243PubMed
37,261,346Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cells.Front Immunol2023https://conductscience.org/library/papers/37261346PubMed
37,190,286Cancer Immunotherapy: Where Next?Cancers (Basel)2023https://conductscience.org/library/papers/37190286PubMed
36,476,657Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy.Br J Cancer2023https://conductscience.org/library/papers/36476657PubMed

1 to 10 of 221

See all 221 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C2717PubTator's text mininghttps://conductscience.org/library/genes/717NCBI Gene
HLA-A3,105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/95015

GET https://conductscience.org/api/papers/v1/95015/cited_by?page=2